2′-Fucosyllactose (2′-FL) is the most abundant human milk oligosaccharide (HMO), playing vital roles in promoting infant gut health, enhancing immunity, and defending against pathogens. However, conventional 2′-FL biosynthesis typically relies on exogenous supplementation of lactose or fucose precursors, leading to high costs and process complexity. In this study, we report a streamlined de novo biosynthesis process for 2′-FL using glucose as the sole carbon source, achieved through systematic engineering of endogenous precursor pathways in E. coli. First, the complete biosynthetic route from glucose to lactose and then to 2′-FL was reconstructed in a chassis strain capable of producing fucose. Unlike previous studies that primarily focused on the GDP-L-fucose supply module, this work systematically balanced the metabolic flux between phosphorylated and non-phosphorylated glucose pools to coordinate the supply of precursors for both lactose and GDP-L-fucose synthesis. This balance was achieved by reconstructing the glucose uptake system, modulating the expression of key enzymes at critical metabolic nodes, and eliminating competing pathways. Subsequently, the endogenous lactose synthesis pathway was further enhanced through coordinated overexpression of pgm, galU, and galE, and the pentose phosphate pathway and purine salvage pathway were optimized to enhance the supply of NADPH and GTP. Using this strategy, an engineered E. coli strain for efficient 2′-FL production was successfully constructed. The engineered strain produced 7.11 g/L 2′-FL in shake-flask fermentation and achieved a titer of 43.2 g/L in a 3-L bioreactor after 58 h, representing the highest reported titer for de novo 2′-FL biosynthesis in E. coli using glucose as the exclusive carbon source without exogenous lactose supplementation.
| [1] |
Bensimon J, Lu X. Human milk oligosaccharides produced by synthetic biology. J Agric Food Res, 2024, 18: 101361.
|
| [2] |
Boteva E, Doychev K, Kirilov K, Handzhiyski Y, Tsekovska R, Gatev E, et al.. Deglycation activity of the Escherichia coli glycolytic enzyme phosphoglucose isomerase. Int J Biol Macromol, 2024, 257: 128541.
|
| [3] |
Cao C, Bai Y, Zhang M, Khan SS, Ji Y, Liu L. Synthesis of 2′-fucosyllactose using multi-enzyme cascade with cofactor regeneration. Sci Rep, 2025, 16: 2457.
|
| [4] |
Cheng YJ, Yeung CY. Recent advance in infant nutrition: Human milk oligosaccharides. Pediatr Neonatol, 2021, 62: 347-53.
|
| [5] |
Chin YW, Seo N, Kim JH, Seo JH. Metabolic engineering of Escherichia coli to produce 2′-fucosyllactose via salvage pathway of guanosine 5′‐diphosphate (GDP)‐l‐fucose. Biotechnol Bioeng, 2016, 113: 2443-52.
|
| [6] |
Cho KM, Hong DK, Wang S, Jin YS, Yun EJ, Kim KH. Enhanced production of 2-fucosylgalactose from renewable substrates via GDP-L-fucose pathway optimization in Escherichia coli. Food Biosci, 2025, 72: 107477.
|
| [7] |
Fang H, Gao J, Mund NK, Tan Y, Shi P, Zhao C. Recent advances in metabolic engineering strategies for the production of human milk oligosaccharides in microbial hosts. ACS Synth Biol, 2025, 14: 2885-905.
|
| [8] |
Liang S, Ying C, Han D, Xia X, Yang S, Jiang Z. High-Level Production of 2′-Fucosyllactose in Escherichia coli by Systematic Metabolic Engineering. J Agric Food Chem, 2026, 74: 1110-19.
|
| [9] |
Li C, Wu M, Gao X, Zhu Z, Li Y, Lu F, et al.. Efficient Biosynthesis of 2′-Fucosyllactose Using an In Vitro Multienzyme Cascade. J Agric Food Chem, 2020, 68: 10763-71.
|
| [10] |
Li M, Li C, Luo Y, Hu M, Liu Z, Zhang T. Multi-level metabolic engineering of Escherichia coli for high‐titer biosynthesis of 2′‐fucosyllactose and 3‐fucosyllactose. Microb Biotechnol, 2022, 15: 2970-81.
|
| [11] |
Li M, Luo Y, Hu M, Li C, Liu Z, Zhang T. Module-Guided Metabolic Rewiring for Fucosyllactose Biosynthesis in Engineered Escherichia coli with Lactose De Novo Pathway. J Agric Food Chem, 2022, 70: 14761-70.
|
| [12] |
Liu JY, Miller PF, Willard J, Olson ER. Functional and biochemical characterization of Escherichia coli sugar efflux transporters. J Biol Chem, 1999, 274: 22977-84.
|
| [13] |
Liu T, Zhang K, Zhang M, Wang L, Wu Y, Cai B, et al.. De novo synthesis of lacto-N-neotetraose in Escherichia coli through metabolic engineering with glucose as the sole carbon source. J Agric Food Chem, 2025, 73: 13736-45.
|
| [14] |
Liu Y, Zhu Y, Wang H, Wan L, Zhang W, Mu W. Strategies for Enhancing Microbial Production of 2′-Fucosyllactose, the Most Abundant Human Milk Oligosaccharide. J Agric Food Chem, 2022, 70: 11481-99.
|
| [15] |
Ma C, Zhang C, Fan L, Deng C, Zhao L. De novo 2′-fucosyllactose bioproduction through modular engineering of a novel Escherichia coli K12‐derived strain. Food Bioeng, 2023, 2: 89-104.
|
| [16] |
Malykh EA, Golubeva LI, Kovaleva ES, Shupletsov MS, Rodina EV, Mashko SV, et al.. H+-translocating membrane-bound pyrophosphatase from Rhodospirillum rubrum fuels Escherichia coli cells via an alternative pathway for energy generation. Microorganisms, 2023, 11: 294.
|
| [17] |
Park BS, Yoon J, Lee JM, Cho SH, Choi Y, Cho BK, et al.. Metabolic engineering of Priestia megaterium for 2’-fucosyllactose production. Microb Cell Fact, 2025, 24: 2.
|
| [18] |
Renwick S, Furst A, Knip M, Bode L, Danska JS, Allen Vercoe E, et al.. Modulating the developing gut microbiota with 2’-fucosyllactose and pooled human milk oligosaccharides. Microbiome, 2025, 13: 44.
|
| [19] |
Srinivasan VB, Singh B, Rajamohan G. Engineering Microbial Pathways for the Production of 2′-Fucosyllactose. Microb Nutraceut, 2025.
|
| [20] |
Sugita T, Koketsu K. Transporter engineering enables the efficient production of lacto-N-triose II and lacto-N-tetraose in Escherichia coli. J Agric Food Chem, 2022, 70: 5106-14.
|
| [21] |
Vandenplas Y, Berger B, Carnielli VP, Ksiazyk J, Lagström H, Sanchez Luna M, et al.. Human milk oligosaccharides: 2′-fucosyllactose (2′-FL) and lacto-N-neotetraose (LNnT) in infant formula. Nutrients, 2018, 10: 1161.
|
| [22] |
Wang L, Zhang K, Gao S, Zhang M, Liu T, Cai B, et al.. High-yield synthesis of 2′-fucosyllactose from glycerol and glucose in engineered Escherichia coli. J Agric Food Chem, 2023, 71: 15237-48.
|
| [23] |
Wiciński M, Sawicka E, Gębalski J, Kubiak K, Malinowski B. Human milk oligosaccharides: health benefits, potential applications in infant formulas, and pharmacology. Nutrients, 2020, 12: 266.
|
| [24] |
Wu X, Cao T, Ye J, Shi R, Bao X, Ge Y, et al.. Supplementation of 2′-Fucosyllactose during the Growth Period Improves Neurodevelopmental Disorders in Offspring Mice Induced by Maternal Immune Activation. J Agric Food Chem, 2025, 73: 12292-307.
|
| [25] |
Xia T, Han Q, Costanzo WV, Zhu Y, Urbauer JL, Eiteman MA. Accumulation of d-glucose from pentoses by metabolically engineered Escherichia coli. Appl Environ Microbiol, 2015, 81: 3387-94.
|
| [26] |
Yao R, Hirose Y, Sarkar D, Nakahigashi K, Ye Q, Shimizu K. Catabolic regulation analysis of Escherichia coli and its crp, mlc, mgsA, pgi and ptsG mutants. Microb Cell Fact, 2011, 10: 67.
|
| [27] |
You R, Wang L, Hu M, Tao Y. Efficient production of 2′-fucosyllactose from fructose through metabolically engineered recombinant Escherichia coli. Microb Cell Fact, 2024, 23: 38.
|
| [28] |
Yu S, Liu JJ, Yun EJ, Kwak S, Kim KH, Jin YS. Production of a human milk oligosaccharide 2′-fucosyllactose by metabolically engineered Saccharomyces cerevisiae. Microb Cell Fact, 2018, 17: 101.
|
| [29] |
Zhang M, Zhang K, Liu T, Wang L, Wu M, Gao S, et al.. High-level production of lacto-N-neotetraose in Escherichia coli by stepwise optimization of the biosynthetic pathway. J Agric Food Chem, 2023, 71: 16212-20.
|
| [30] |
Zhang Q, Liu Z, Xia H, Huang Z, Zhu Y, Xu L, et al.. Engineered Bacillus subtilis for the de novo production of 2′-fucosyllactose. Microb Cell Fact, 2022, 21: 110.
|
| [31] |
Zhang Q, Xu X, Zhang W, Huang Z, Wu Y, Liu Y, et al.. De novo 2′-fucosyllactose biosynthesis using glucose as the sole carbon source by multiple engineered Bacillus subtilis. Metab Eng, 2025, 88: 85-93.
|
| [32] |
Zhao J, Baba T, Mori H, Shimizu K. Effect of zwf gene knockout on the metabolism of Escherichia coli grown on glucose or acetate. Metab Eng, 2004, 6: 164-74.
|
| [33] |
Zhou W, Jiang H, Wang L, Liang X, Mao X. Biotechnological Production of 2′-Fucosyllactose: A Prevalent Fucosylated Human Milk Oligosaccharide. ACS Synth Biol, 2021, 10: 447-58.
|
| [34] |
Zhu Y, Cao H, Wang H, Mu W. Biosynthesis of human milk oligosaccharides via metabolic engineering approaches: current advances and challenges. Curr Opin Biotechnol, 2022, 78: 102841.
|
| [35] |
Zhu Y, Chen R, Wang H, Chen Y, Liu Y, Zhou J, et al.. Elimination of Byproduct Generation and Enhancement of 2′-Fucosyllactose Synthesis by Expressing a Novel α1,2-Fucosyltransferase in Engineered Escherichia coli. J Agric Food Chem, 2023, 71: 4915-23.
|
| [36] |
Zhu Y, Wan L, Li W, Ni D, Zhang W, Yan X, et al.. Recent advances on 2′-fucosyllactose: physiological properties, applications, and production approaches. Crit Rev Food Sci Nutr, 2022, 62: 2083-92.
|
| [37] |
Zhu Y, Xu F, Yang L, Zhang W, Chen Y, Mu W. Advances and Challenges of 2′-Fucosyllactose: Physiological Function and Biotechnological Production. J Agric Food Chem, 2026, 74: 2470-84.
|
| [38] |
Zhu Y, Zhang W, Mu W. Human Milk Oligosaccharides: The New Gold Standard for Premium Infant Formula. J Agric Food Chem, 2022, 70: 2061-63.
|
| [39] |
Zhu Y, Zhao M, Wang H, Zhu Y, Mu W. Metabolic engineering of Escherichia coli BL21(DE3) cocultured with glucose and xylose for efficient production of 2′-fucosyllactose. Bioresour Technol, 2025, 419: 132062.
|
Funding
National Key Research and Development Program of China(2024YFF1106300)
RIGHTS & PERMISSIONS
Jiangnan University
PDF
